Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Valeriya, Semenisty"'
Autor:
Yaacov Richard Lawrence, Sivan Lieberman, Ilanit Redinsky, Nir Honig, Einat Shacham-Shmueli, Naama Halpern, Stephen Raskin, Damien Urban, Aliza Ackerstein, Maoz Ben-Ayun, Katerina Shulman, Eitan Ben-Ami, Valeriya Semenisty, Ofer Purim, Nirit Yarom, Talia Golan, Ben Boursi, Lina Ziegler, Art M. Krieg, Ofer Margalit
Publikováno v:
Journal of Clinical Oncology. 41:123-123
123 Background: Microsatellite stable (MSS) or mismatch repair proficient (MMR-P) metastatic colorectal cancer is refractory to immune checkpoint inhibition. We hypothesized that a combination of intratumoral TLR9 agonist, radiosurgery and dual PD-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f99604bbfcc4c1abb1dcf94d0a71850a
https://doi.org/10.1200/jco.2023.41.4_suppl.123
https://doi.org/10.1200/jco.2023.41.4_suppl.123
Autor:
Galit, Hirsh-Yechezkel, Angela, Chetrit, Sivan, Ben Avraham, Abed, Agbarya, Alexander, Yakobson, Noam, Asna, Gil, Bar-Sela, Irit, Ben-Aharon, Noa Efrat, Ben-Baruch, Raanan, Berger, Ronen, Brenner, Maya, Gottfried, Shani, Paluch-Shimon, Raphael, Pfeffer, Aron, Popovtzer, Larisa, Ryvo, Valeriya, Semenisty, Ayelet, Shai, Katerina, Shulman, Jamal, Zidan, Ido, Wolf
Publikováno v:
The Israel Medical Association journal : IMAJ. 23(12)
The increased susceptibility of cancer patients to coronavirus disease-2019 (COVID-19) infections and complications calls for special precautions while treating cancer patients during COVID-19 pandemics. Thus, oncology departments have had to impleme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de57349ce66c80e6a18fa673e7f4819b
https://pubmed.ncbi.nlm.nih.gov/34954913
https://pubmed.ncbi.nlm.nih.gov/34954913
Autor:
Diana Matceyevsky, Moshe Inbar, Felix Bokstein, Baruch Brenner, Arie Figer, Tamar Peretz, Lior Soussan-Gutman, Addie Dvir, Ronen Brenner, Ayala Hubert, Amiel Segal, Elizabeth Dudnik, Alexander Beny, David Sarid, Andreas Voss, Ofer Purim, Katerina Shulman, Mark Temper, Sharon Pelles-Avraham, Efraim Idelevich, Amichay Meirovitz, Valeriya Semenisty, D. Limon, Kenneth J. Russell
Publikováno v:
Targeted Oncology
Background Precision treatment of cancer uses biomarker-driven therapy to individualize and optimize patient care. Objective To evaluate real-life clinical experience with biomarker-driven therapy in metastatic gastric and esophageal cancer in Israel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c72f7f0ae542aa81fbae21b9658b6ae
https://doi.org/10.1007/s11523-017-0548-8
https://doi.org/10.1007/s11523-017-0548-8
Autor:
Celina Ang, Talia Golan, Rosario Ligresti, Eithan Galun, Shay Rotkopf, Racheli Gabai-Malka, Nirit Yarom, Christopher J. DiMaio, Mark A. Schattner, Martin Gutierrez, Salomon M. Stemmer, Amotz Shemi, Anna M. Varghese, Iyad Khamaysi, Valeriya Semenisty, Ravit Geva, Milind Javle, Eileen M. O'Reilly
Publikováno v:
Journal of Clinical Oncology. 38:TPS4672-TPS4672
TPS4672 Background: KRAS alterations are the most frequent driver alterations identified in pancreas cancer; however, KRAS has remained an elusive therapeutic target. siG12D-LODER is a novel, miniature bio-degradable polymeric matrix encompassing a n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0232fed789c25de9e657c2633c014507
https://doi.org/10.1200/jco.2020.38.15_suppl.tps4672
https://doi.org/10.1200/jco.2020.38.15_suppl.tps4672
Autor:
Yulia Kaplan, Lior H. Katz, Yuval Yaron, Orit Reish, Lior Soussan Gutman, Rachel Michaelson-Cohen, Shani Paluch-Shimon, Valeriya Semenisty, Addie Dvir, Inbal Barnes-Kedar, Noa Efrat, Tamar Yablonski-Peretz, Tamar Safra, Eitan Friedman, Victoria Neiman, Talia Golan, Ayala Hubert, Yafit Glasser, Luna Kadouri, Bella Kaufman
Publikováno v:
Breast cancer research and treatment. 155(1)
We evaluated the clinical utility of screening for mutations in 34 breast/ovarian cancer susceptibility genes in high-risk families in Israel. Participants were recruited from 12, 2012 to 6, 2015 from 8 medical centers. All participants had high brea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbe0c0b3fb90641809f6e2cbe219eade
https://pubmed.ncbi.nlm.nih.gov/26687385
https://pubmed.ncbi.nlm.nih.gov/26687385
Autor:
Daniel Shahar, Tanya Mashiac, Eliahu Gez, David Kakiashvili, Abraham Kuten, Rachel Bar Deroma, Simon Meretyck, Valeriya Semenisty, Joshua Genesin
Publikováno v:
Journal of Radiotherapy in Practice. 11:16-22
Background: In low-risk prostate cancer, the target volume for radiotherapy is the prostate gland only and prostate brachytherapy with an I-125 implant provides the most conformal radiotherapy.Methods: Patients underwent a pre-implant prostate volume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f842491d33ce4fd7460f307446a99bc8
https://doi.org/10.1017/s1460396910000531
https://doi.org/10.1017/s1460396910000531
Autor:
Amnon Peled, Joon Oh Park, Carlos Becerra, Galia Oberkovitz, Valeriya Semenisty, Steven Shaw, Robert A. Ramirez, Tzipora M. Lustig, Salomon M. Stemmer, Katrina Pedersen, Daniel D. Von Hoff, Ron Epelbaum, Manuel Hidalgo, Mitesh J. Borad, Ella Sorani, Erkut Borazanci, Talia Golan, Brian M. Wolpin, Ravit Geva, Abi Vainstein Haras
Publikováno v:
Journal of Clinical Oncology. 36:88-88
276 Background: BL-8040 is a novel CXCR4 antagonist being developed for multiple oncology indications. Preclinical studies demonstrated that BL-8040 increases the number of immune cells in peripheral blood and promotes CD8+ T cell infiltration into o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc61a62df7e94fa034ae06a233952e00
https://doi.org/10.1200/jco.2018.36.5_suppl.88
https://doi.org/10.1200/jco.2018.36.5_suppl.88
Publikováno v:
BMC Cancer
Background Epithelioid hemangioendothelioma is a rare vascular tumor of borderline or low-grade malignancy. The lungs and liver are the two common primary organs affected. Metastatic disease was reported in more than 100 cases in the literature. Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a15ae7bb1b4ae91bea16d109f8d3a1bb
http://europepmc.org/articles/PMC4437555
http://europepmc.org/articles/PMC4437555
Autor:
Felix Bokstein, Sharon Pelles, Ronen Brenner, Dror Limon, Baruch Brenner, Addie Dvir, Moshe Inbar, Efraim Idelevich, Lior Soussan-Gutman, Andreas Voss, Elizabeth Dudnik, Amichay Meirovitz, David Sarid, Tamar Peretz, Alexander Beny, Ayala Hubert, Kenneth J. Russell, Ofer Purim, Mark Temper, Valeriya Semenisty
Publikováno v:
Journal of Clinical Oncology. 35:e15537-e15537
e15537 Background: We evaluated real-life clinical experience with molecular profiling (MP)-guided therapy in metastatic gastric and oesophageal cancer in Israel Methods: This multicenter retrospective cohort study included patients with metastatic g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1a793c76c5b3c6131bc93ae43043af9
https://doi.org/10.1200/jco.2017.35.15_suppl.e15537
https://doi.org/10.1200/jco.2017.35.15_suppl.e15537